The last several years have seen an explosion of studies showing relationships between cognitive performance and sex steroid supplementation in men and women. These studies are most notable for their implications for cognitive aging and because they raise the possibility of protection against age-related neurologic diseases or age-related cognitive decline. The mechanism(s) that underlie the cognitive effects of sex steroids in humans are unknown. The overall goal of this research program is to initiate studies of the metabolic pathways that underlie the cognitive effects of sex steroids in human aging. Therefore, we will examine which androgen pathway underlies cognitive effects of androgen supplementation in men (Aim 1) by comparing cognitive performance before and after manipulation of sex steroids. We will administer a gonadotropin releasing hormone agonist, and simultaneously replaced with testosterone (T), T+ an aromatase inhibitor (preventing T's conversion to estradiol (E2)), or a placebo in a double blind manner in both younger and older men. We will examine whether T has cognitive effects in older women and the pathway of these effects by testing cognition in older women before and after T, T+aromatase inhibitor, E2 alone, or no replacement (Aim 2). This research program utilizes a cognitive neuroscience framework such that the critical brain systems for each cognitive domain (working memory, perception, verbal and nonverbal memory, motor sequence learning) have been delineated in previous studies. The tasks are those that particularly decline in aging, and have shown sex differences and/or sex steroid effects in previous studies. Findings that cognitive effects are due to aromatization to E2 in men versus action at T receptors, and findings that T affects cognition in women would give significant direction to the creation of tissue specific, sex steroid-related pharmacologic treatments for brain aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG018843-01A2
Application #
6580506
Study Section
Special Emphasis Panel (ZRG1-IFCN-4 (04))
Program Officer
Wagster, Molly V
Project Start
2003-05-01
Project End
2007-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
1
Fiscal Year
2003
Total Cost
$363,207
Indirect Cost
Name
Oregon Health and Science University
Department
Neurology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Roalf, David R; Mitchell, Suzanne H; Harbaugh, William T et al. (2012) Risk, reward, and economic decision making in aging. J Gerontol B Psychol Sci Soc Sci 67:289-98
Roalf, David R; Pruis, Trisha A; Stevens, Alexander A et al. (2011) More is less: emotion induced prefrontal cortex activity habituates in aging. Neurobiol Aging 32:1634-50
Young, Laura A; Neiss, Michelle B; Samuels, Mary H et al. (2010) Cognition is not modified by large but temporary changes in sex hormones in men. J Clin Endocrinol Metab 95:280-8
Pruis, T A; Roalf, D R; Janowsky, J S (2009) Hormone therapy does not modify emotion-induced brain activity in older women. Horm Behav 56:539-47
Siegel, Jessica A; Young, Laura A; Neiss, Michelle B et al. (2008) Estrogen, testosterone, and sequential movement in men. Behav Neurosci 122:955-62
Ha, Duy M; Xu, Jingang; Janowsky, Jeri S (2007) Preliminary evidence that long-term estrogen use reduces white matter loss in aging. Neurobiol Aging 28:1936-40
Beer, Tomasz M; Bland, Lisa B; Bussiere, Joseph R et al. (2006) Testosterone loss and estradiol administration modify memory in men. J Urol 175:130-5
Janowsky, J S (2006) The role of androgens in cognition and brain aging in men. Neuroscience 138:1015-20
Bussiere, Joseph R; Beer, Tomasz M; Neiss, Michelle B et al. (2005) Androgen deprivation impairs memory in older men. Behav Neurosci 119:1429-37